Astellas to double drug manufacturing capacity at Tralee facility

Astellas announced plans to double drug manufacturing capacity at its Tralee facility, reinforcing its commitment to Ireland. The expansion signals increased investment in Irish pharma operations, though financial details and timeline remain unspecified. This is a corporate investment decision with potential local economic impact but limited macro-market relevance.